~7 spots leftby May 2025

Occupational Intervention for ADHD

Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Université du Québec a Montréal
Disqualifiers: Receiving psychosocial services

Trial Summary

What is the purpose of this trial?An adaptation of the Minds@Work intervention to improve quality of life at work for adults living with attention deficit disorder with/without hyperactivity (ADHD), following a group format.
Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Minds@Work-ADHD-Quality of Life for ADHD?

Research on a similar treatment, Work-MAP, shows that a telehealth intervention can improve work performance, executive functions (mental skills like planning and organizing), and quality of life for adults with ADHD. This suggests that the Minds@Work-ADHD-Quality of Life treatment might also be effective in enhancing these areas.

12345
How is the Minds@Work-ADHD-Quality of Life treatment different from other ADHD treatments?

Minds@Work-ADHD-Quality of Life is unique because it focuses on improving work participation and quality of life through occupational interventions, specifically addressing executive impairments (difficulties in planning, organizing, and managing tasks) in adults with ADHD. Unlike traditional medication, this treatment involves personalized support from occupational specialists to enhance daily functioning and work performance.

12678

Eligibility Criteria

This trial is for adults who have been diagnosed with Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD). Specific eligibility criteria are not provided, but typically participants would need to meet diagnostic criteria for ADHD and be seeking ways to improve their work life.

Inclusion Criteria

French language proficiency
Score ≤ 4 on Part A of the Adult ADHD Self-Report Scale (ASRS-v1.1)
Currently employed
+2 more

Exclusion Criteria

I am getting therapy to help improve my quality of life.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the Minds@Work psychosocial group intervention aimed at improving quality of life at work for ADHD workers

8 weeks
Weekly group sessions

Follow-up

Participants are monitored for maintenance of intervention gains at multiple time points

12 months
Assessments at 3, 6, 9, and 12 months post-intervention

Participant Groups

The study is testing an adapted version of the Minds@Work intervention, designed specifically to enhance the quality of work life for those living with ADHD. It's a group-based program that may involve minimal contact with facilitators.
2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
Minds@Work-ADHD-Quality of Life
Group II: ControlPlacebo Group1 Intervention
Minimal contact comparison approach

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Université du Québec à MontréalMontréal, Canada
Loading ...

Who Is Running the Clinical Trial?

Université du Québec a MontréalLead Sponsor
Fonds de recherche du Québec - Société et cultureCollaborator

References

Work-MAP Telehealth Metacognitive Work-Performance Intervention for Adults With ADHD: Randomized Controlled Trial. [2023]The literature highlighted the need for evidence-based occupational therapy teleinterventions to improve work participation among adults with attention-deficit/hyperactivity disorder (ADHD). This study aimed to assess the efficacy of a self-tailored, metacognitive, telehealth intervention to enhance the performance of adults with ADHD at work (Work-MAP). The outcome measures were efficacy and satisfaction with performing self-selected work goals, executive functions, and quality of life. Participants in this randomized controlled trial were 46 adults with ADHD. Group A (n = 31) received the synchronous, hybrid-telehealth intervention in 11-weekly 1-hour individual sessions. Group B (n = 15) completed the intervention after a waiting phase. Following the intervention, participants showed and maintained significant improvements in all outcome measures (strong-to-moderate significant effects) to the 3-month follow-up. The Work-MAP teleintervention appears effective for improving work participation (i.e., performance), executive functions, and quality of life of adults with ADHD.
Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. [2022]To determine the effects of symptom profile, comorbid psychiatric problems, and treatment on occupational outcome in adult ADHD patients.
Functional impairment and occupational outcome in adults with ADHD. [2022]ADHD is associated with poor functional outcomes. The objectives were to investigate the prevalence of functional impairment and occupational status in a clinically referred sample of adults with ADHD and explore factors predicting occupational outcome.
A systematic review of interventions to support adults with ADHD at work-Implications from the paucity of context-specific research for theory and practice. [2022]Attention Deficit Hyperactivity Disorder (ADHD) is estimated to affect 3.5% of the global workforce. Despite the high prevalence rate, little is known about how best to support adults with ADHD (ADHDers) at work. Relevant research is dispersed across different disciplines such as medicine, health studies and psychology. Therefore, it is important to synthesize interventions aimed at ADHDers to examine what learning can be gleaned for effective workplace support. We conducted a systematic review of relevant interventions framed by realist evaluation and the Context-Intervention-Mechanism-Outcome classification to identify key mechanisms of effectiveness for workplace interventions. We searched 10 databases including a range of journals from medical science to business management applying predetermined inclusion criteria and quality appraisal through a risk of bias assessment for quantitative and qualitative methods. We synthesized 143 studies with realist evaluation. Most studies evaluated the effectiveness of pharmacological interventions highlighting the dominance of the medical approach to supporting ADHDers. Key mechanisms of effectiveness were identified from psychosocial interventions including group therapy, involvement of people in the ADHDers network, and the importance of the client-patient relationship. Overall, there is limited research that examines the effectiveness of workplace interventions for ADHDers. Furthermore, much of the existing research evaluates pharmacological interventions which is difficult to transfer to the workplace context. It is recommended that future research and practice consider the key mechanisms identified in this review when designing interventions as well as barriers to accessing support such as disclosure and self-awareness.
Efficacy of lisdexamfetamine dimesylate for promoting occupational success in adolescents and young adults with attention-deficit/hyperactivity disorder. [2021]There has been a lack of research on the third area of impairment noted in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-"occupational functioning." It is important to understand the impact of common treatments for attention-deficit/hyperactivity disorder (ADHD) in occupational settings. Twenty individuals with ADHD between ages 16 and 25 participated in a double-blind, placebo controlled evaluation of 40 mg lisdexamfetamine dimesylate in a setting designed to approximate a restaurant workplace with associated, simulated food delivery. Outcome measures included ratings of performance, as well as behavioral productivity. Results indicated that participants completed more workplace tasks when on medication, relative to placebo. Ratings of job application quality, job interview performance, and delivery outcomes were not significantly different on medication versus placebo. These results suggest positive effects of medication in a workplace environment, but also a need for study of additional interventions to support workplace-related behavior and functioning. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Needs for occupational assistance among young adults with ADHD to deal with executive impairments and promote occupational participation - a qualitative study. [2022]To examine perceived aspects of importance among young adults with ADHD to participate and engage in occupational activities, and to explain how support from occupational specialists can assist them to deal with executive impairments.
Functional Impairment Mediates the Relationship Between Adult ADHD Inattentiveness and Occupational Outcome. [2018]In spite of an expanding use of health-related quality of life assessment in research and treatment of ADHD, there is still limited knowledge about the role of impaired quality of life in symptomatic outcomes. This study investigates how specific functional domains affect the relationship between ADHD symptoms and occupational outcome.
Pilot Study of the Cognitive-Functional Intervention for Adults (Cog-Fun A): A Metacognitive-Functional Tool for Adults With Attention Deficit Hyperactivity Disorder. [2022]Adults with attention deficit hyperactivity disorder (ADHD) often experience chronic challenges in their life roles. There is a need for evidence-based occupational therapy interventions to help enhance their functioning.